Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Herbert

Showing results (641-650 of 657) with videos related to

Pageof 66
Sort By:
Cell Reports|January 13, 2021
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial CellsXin Yin, Laura Riva, Yuan Pu, et al.
Plos Computational Biology|September 9, 2011
Towards a system level understanding of non-model organisms sampled from the environment: a network biology approachTim D Williams, Nil Turan, Amer M Diab, et al.
American Heart Journal|January 18, 2025
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemiaGerard T Portela, Gregory Ducrocq, Marnie Bertolet, et al.
Occupational and Environmental Medicine|August 28, 2020
Ambulatory blood pressure monitoring among emergency medical services night shift workersP Daniel Patterson, Kristina A Mountz, Michael G Agostinelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studiesE Bignon, A Bachy, R Boigegrain, et al.
Cell|July 31, 1999
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesisP Carmeliet, M G Lampugnani, L Moons, et al.
Nature Medicine|September 30, 1999
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failureS Heymans, A Luttun, D Nuyens, et al.
Journal of Virology|November 29, 2019
Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa CellsAriel Rodriguez-Frandsen, Laura Martin-Sancho, Anshu P Gounder, et al.
Circulation. Heart Failure|March 26, 2025
Blood Transfusion in Patients With Acute Myocardial Infarction, Anemia, and Heart Failure: Lessons From MINTAndrew M Goldsweig, William J Kostis, Brandon M Herbert, et al.
Nature Medicine|May 1, 2001
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsP Carmeliet, L Moons, A Luttun, et al.
Pageof 66

Showing results (641-650 of 657) with videos related to

Sort By:
Pageof 66
Cell Reports|January 13, 2021
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial CellsXin Yin, Laura Riva, Yuan Pu, et al.
Plos Computational Biology|September 9, 2011
Towards a system level understanding of non-model organisms sampled from the environment: a network biology approachTim D Williams, Nil Turan, Amer M Diab, et al.
American Heart Journal|January 18, 2025
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemiaGerard T Portela, Gregory Ducrocq, Marnie Bertolet, et al.
Occupational and Environmental Medicine|August 28, 2020
Ambulatory blood pressure monitoring among emergency medical services night shift workersP Daniel Patterson, Kristina A Mountz, Michael G Agostinelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studiesE Bignon, A Bachy, R Boigegrain, et al.
Cell|July 31, 1999
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesisP Carmeliet, M G Lampugnani, L Moons, et al.
Nature Medicine|September 30, 1999
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failureS Heymans, A Luttun, D Nuyens, et al.
Journal of Virology|November 29, 2019
Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa CellsAriel Rodriguez-Frandsen, Laura Martin-Sancho, Anshu P Gounder, et al.
Circulation. Heart Failure|March 26, 2025
Blood Transfusion in Patients With Acute Myocardial Infarction, Anemia, and Heart Failure: Lessons From MINTAndrew M Goldsweig, William J Kostis, Brandon M Herbert, et al.
Nature Medicine|May 1, 2001
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsP Carmeliet, L Moons, A Luttun, et al.
Pageof 66